What Is Circadian Rhythm

Circadian rhythm is the approximately 24-hour internal cycle that regulates sleep, wakefulness, hormone secretion, body temperature, and cellular metabolism across virtually all tissues. It is generated by molecular clock genes that produce proteins in self-sustaining feedback loops and is synchronized to the external environment primarily through light exposure. When this rhythm aligns with the day-night cycle, it coordinates physiology in a way that supports repair, energy production, and immune function at the appropriate times.

Nearly every physiological process relevant to aging and healthspan operates on a circadian schedule. Growth hormone secretion peaks during deep sleep in the first half of the night. Cortisol rises before waking to mobilize energy. DNA repair enzymes are most active during rest. Insulin sensitivity follows a daily arc, typically highest in the morning and lowest at night. When these processes fire at the wrong times, the cumulative metabolic cost accelerates biological aging.

Epidemiological data from shift workers and populations with irregular light exposure consistently show higher rates of metabolic syndrome, cardiovascular disease, certain cancers, and cognitive decline. Animal studies demonstrate that disrupting clock gene function shortens lifespan and accelerates tissue degeneration, independent of sleep duration alone. Circadian alignment is not simply about getting enough sleep; it is about ensuring the body's maintenance, defense, and metabolic programs run in the correct sequence and at the right intensity.

The molecular basis of circadian rhythm is a transcription-translation feedback loop. Core clock genes (CLOCK and BMAL1) activate the transcription of Period (PER) and Cryptochrome (CRY) genes. The PER and CRY proteins accumulate, form complexes, and eventually inhibit CLOCK/BMAL1 activity, shutting down their own production. As PER and CRY proteins degrade over several hours, the inhibition lifts and the cycle restarts. This loop takes roughly 24 hours, and it runs in virtually every nucleated cell in the body.

The suprachiasmatic nucleus (SCN) in the anterior hypothalamus acts as the master pacemaker. It receives photic input through the retinohypothalamic tract from intrinsically photosensitive retinal ganglion cells (ipRGCs) that are most sensitive to short wavelength (blue) light around 480 nanometers. The SCN synchronizes peripheral clocks in the liver, pancreas, adipose tissue, and immune cells through neural signals, hormonal outputs like melatonin and cortisol, and body temperature fluctuations. Melatonin, produced by the pineal gland under SCN control, rises in darkness to promote sleep onset and falls with morning light.

Peripheral clocks are not just passive recipients of SCN signals. They respond independently to local cues such as feeding times, exercise, and temperature. The liver clock, for example, can be shifted by altering meal timing even when the SCN remains entrained to the light cycle. This creates the possibility of internal desynchrony, where the master clock and peripheral clocks are out of phase. Such misalignment appears to contribute to metabolic dysfunction, including impaired glucose tolerance and altered lipid metabolism, because enzymes and transporters that handle nutrients are expressed at times when no food is being processed, or vice versa.

The molecular circadian clock was well enough characterized by 2017 that the Nobel Prize in Physiology or Medicine was awarded for discoveries of molecular mechanisms controlling circadian rhythm. Large epidemiological studies of shift workers, comprising hundreds of thousands of participants, have consistently associated chronic circadian disruption with elevated risk for type 2 diabetes, cardiovascular disease, breast cancer, and all-cause mortality. Controlled laboratory studies using forced desynchrony protocols demonstrate that even a few days of circadian misalignment impair glucose tolerance, raise blood pressure, and alter inflammatory markers in otherwise healthy adults.

Animal research has shown that genetic disruption of core clock genes accelerates aging phenotypes and shortens lifespan. Time-restricted feeding, which aligns food intake with the active circadian phase, has shown metabolic benefits in rodent studies even without calorie reduction, though human trials are still accumulating and results are more mixed. Clinical trials on timed light exposure for mood and sleep disorders are relatively robust, while research on circadian-timed drug administration (chronotherapy) is growing but still limited in most therapeutic areas. Gaps remain in understanding individual variation in circadian sensitivity, the long-term reversibility of chronic disruption, and optimal strategies for people whose work schedules require nighttime wakefulness.

Rigid adherence to a circadian protocol can become counterproductive if it creates anxiety around timing or conflicts with unavoidable social and professional obligations. Some individuals have genetic chronotypes that make very early or very late schedules biologically natural, and forcing a mismatch with one's endogenous rhythm can be as disruptive as ignoring the clock entirely. Melatonin supplementation, sometimes used to shift circadian phase, can interact with other hormonal systems and may not be appropriate for everyone. Shift workers face a genuine dilemma, because the evidence on circadian disruption is concerning but practical solutions remain incomplete; those in such situations benefit from individualized guidance rather than generic advice.